Detalhe da pesquisa
1.
Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes.
J Hepatol
; 2024 Mar 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38548067
2.
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
Lancet
; 402(10406): 988-996, 2023 09 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37572680
3.
Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort.
J Hepatol
; 78(3): 501-512, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36423805
4.
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.
Hepatology
; 75(1): 219-228, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34537988
5.
Bulevirtide with or without pegIFNα for patients with compensated chronic hepatitis delta: From clinical trials to real-world studies.
J Hepatol
; 77(5): 1422-1430, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35752223
6.
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population.
Clin Gastroenterol Hepatol
; 20(11): 2567-2576.e6, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34971806
7.
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts.
Liver Int
; 42(6): 1386-1400, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35025128
8.
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
BMC Public Health
; 22(1): 1385, 2022 07 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35854275
9.
Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.
Dig Dis Sci
; 66(3): 881-898, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32303953
10.
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta.
J Hepatol
; 73(5): 1046-1062, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32634548
11.
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
J Hepatol
; 73(6): 1434-1445, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32615276
12.
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Gastroenterology
; 156(4): 997-1009.e5, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30768988
13.
Hepatic Sarcoidosis: Current Concepts and Treatments.
Semin Respir Crit Care Med
; 41(5): 652-658, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32777850
14.
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia.
J Hepatol
; 71(6): 1141-1151, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31470067
15.
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
Gastroenterology
; 155(5): 1436-1450.e6, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30031138
16.
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Gastroenterology
; 155(2): 431-442.e10, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29729258
17.
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.
J Viral Hepat
; 26(3): 384-396, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30380181
18.
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication.
Hepatology
; 68(4): 1245-1259, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29663511
19.
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
J Hepatol
; 69(6): 1274-1283, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30092234
20.
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
Gastroenterology
; 152(1): 142-156.e2, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27641509